Cardiovascular disease and giant cell arteritis Archives

Abstract Number: 2772 • ACR/ARHP Annual Meeting 2018
Incidence of Cardiovascular Events in Giant Cell Arteritis: A Matched-Control Study
Florencia Beatriz Mollerach¹, Marina Scolnik², Nicolas Martin Marin Zucaro³, Jose Maximiliano Martinez P⁴ and Enrique R Soriano², ¹Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology Unit, Internal Medicine Service. Hospital Italiano Buenos Aires. Argentina, Buenos Aires, Argentina, ³Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Capital Federal, Argentina, ⁴Rheumatology, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
Background/Purpose: Cardiovascular risk in systemic vasculitis may be higher than in normal population, but there is scarce data. Ethnic component plays a role on certain…
Abstract Number: 1671 • ACR/ARHP Annual Meeting 2013
Cardiovascular Risk At Incidence Of Giant Cell Arteritis: A Population Based Retrospective Cohort Study
P. Deepak Udayakumar¹, Arun K. Chandran¹, Cynthia S. Crowson², Kenneth J. Warrington³ and Eric L. Matteson¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Division of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Many systemic inflammatory rheumatic conditions are associated with increased cardiovascular (CV) risk. We aimed at assessing the CV risk at incidence of giant cell…
Abstract Number: 1673 • ACR/ARHP Annual Meeting 2013
Risk Of Myocardial Infarction In Patients With Giant Cell Arteritis: A Population-Based Study
Neda Amiri¹, Hyon K. Choi^2,3, Eric C. Sayre³, Kamran Shojania^3,4 and J. Antonio Avina-Zubieta^5,6, ¹University of British Columbia, Vancouver, BC, Canada, ²Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Rheumatology, University of British Columbia, Vancouver, BC, Canada, ⁵Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, ⁶Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Involvement of large arteries leading to stenosis is well-documented in giant cell arteritis (GCA), but limited data are available on the risk of coronary…
Abstract Number: 2384 • ACR/ARHP Annual Meeting 2012
Giant Cell Arteritis and Cardiovascular Events in the French Apogee Cohort. A Population-Based Study Using the French Health Insurance System Database
Grégory Pugnet¹, Laurent Sailler², Robert Bourrel³, Jean-Louis Montastruc⁴ and Maryse Lapeyre-Mestre⁴, ¹Department of Internal Medicine, Toulouse University Hospital, University of Toulouse, INSERM UMR 1027, Toulouse, France, ²Department of Internal Medicine, Toulouse University Hospital, Toulouse, France, ³Service Médical, Caisse Nationale de l'Assurance Maladie échelon régional, Midi-Pyrénées, Toulouse, France, ⁴Department of Clinical Pharmacology, Toulouse University Hospital, INSERM U1027, University of Toulouse, France, Toulouse, France
Background/Purpose: The risk of cardiovascular events (CVE) during giant cell arteritis (GCA) has rarely been quantified in population-based studies. Our objective was to quantify the…

Abstracts tagged "Cardiovascular disease and giant cell arteritis"

Incidence of Cardiovascular Events in Giant Cell Arteritis: A Matched-Control Study

Cardiovascular Risk At Incidence Of Giant Cell Arteritis: A Population Based Retrospective Cohort Study

Risk Of Myocardial Infarction In Patients With Giant Cell Arteritis: A Population-Based Study

Giant Cell Arteritis and Cardiovascular Events in the French Apogee Cohort. A Population-Based Study Using the French Health Insurance System Database